These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 29338580)

  • 1. Paeonol nanoemulsion for enhanced oral bioavailability: optimization and mechanism.
    Chen S; Zhang J; Wu L; Wu H; Dai M
    Nanomedicine (Lond); 2018 Feb; 13(3):269-282. PubMed ID: 29338580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of colchicine oral bioavailability by incorporating eugenol in the nanoemulsion as an oil excipient and enhancer.
    Shen Q; Wang Y; Zhang Y
    Int J Nanomedicine; 2011; 6():1237-43. PubMed ID: 21753875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple nanoemulsion system for an oral combinational delivery of oxaliplatin and 5-fluorouracil: preparation and in vivo evaluation.
    Pangeni R; Choi SW; Jeon OC; Byun Y; Park JW
    Int J Nanomedicine; 2016; 11():6379-6399. PubMed ID: 27942212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoemulsion-based delivery system for enhanced oral bioavailability and caco-2 cell monolayers permeability of berberine hydrochloride.
    Li YJ; Hu XB; Lu XL; Liao DH; Tang TT; Wu JY; Xiang DX
    Drug Deliv; 2017 Nov; 24(1):1868-1873. PubMed ID: 29191058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Non-Lipolysis Nanoemulsion Improved Oral Bioavailability by Reducing the First-Pass Metabolism of Raloxifene, and Related Absorption Mechanisms Being Studied.
    Ye JY; Chen ZY; Huang CL; Huang B; Zheng YR; Zhang YF; Lu BY; He L; Liu CS; Long XY
    Int J Nanomedicine; 2020; 15():6503-6518. PubMed ID: 32922013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoemulsion for Improving the Oral Bioavailability of Hesperetin: Formulation Optimization and Absorption Mechanism.
    Zeng F; Wang D; Tian Y; Wang M; Liu R; Xia Z; Huang Y
    J Pharm Sci; 2021 Jun; 110(6):2555-2561. PubMed ID: 33652015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Denatured globular protein and bile salt-coated nanoparticles for poorly water-soluble drugs: Penetration across the intestinal epithelial barrier into the circulation system and enhanced oral bioavailability.
    He W; Yang K; Fan L; Lv Y; Jin Z; Zhu S; Qin C; Wang Y; Yin L
    Int J Pharm; 2015 Nov; 495(1):9-18. PubMed ID: 26325310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of paeonol-loaded transethosomes as transdermal delivery carriers.
    Chen ZX; Li B; Liu T; Wang X; Zhu Y; Wang L; Wang XH; Niu X; Xiao Y; Sun Q
    Eur J Pharm Sci; 2017 Mar; 99():240-245. PubMed ID: 28039091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation optimization and the absorption mechanisms of nanoemulsion in improving baicalin oral exposure.
    Wu L; Bi Y; Wu H
    Drug Dev Ind Pharm; 2018 Feb; 44(2):266-275. PubMed ID: 29022400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemistry, pharmacokinetics, pharmacology and recent novel drug delivery systems of paeonol.
    Adki KM; Kulkarni YA
    Life Sci; 2020 Jun; 250():117544. PubMed ID: 32179072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced bioavailability and antihypertensive activity of nisoldipine loaded nanoemulsion: optimization, cytotoxicity and uptake across Caco-2 cell line, pharmacokinetic and pharmacodynamic studies.
    Mundada VP; Patel MH; Mundada PK; Sawant KK
    Drug Dev Ind Pharm; 2020 Mar; 46(3):376-387. PubMed ID: 32031412
    [No Abstract]   [Full Text] [Related]  

  • 12. Fabrication of Luteolin Nanoemulsion by Box-Behnken Design to Enhance its Oral Absorption Via Lymphatic Transport.
    Tu L; Wang J; Sun Y; Wan Y
    AAPS PharmSciTech; 2024 Sep; 25(7):206. PubMed ID: 39237659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoemulsion as a strategy for improving the oral bioavailability and anti-inflammatory activity of andrographolide.
    Yen CC; Chen YC; Wu MT; Wang CC; Wu YT
    Int J Nanomedicine; 2018; 13():669-680. PubMed ID: 29440893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of Polysorbate 60 on Formulation Properties and Bioavailability of Morin-Loaded Nanoemulsions with and without Low-Saponification-Degree Polyvinyl Alcohol.
    Ikeuchi-Takahashi Y; Kobayashi A; Ishihara C; Matsubara T; Matsubara H; Onishi H
    Biol Pharm Bull; 2018; 41(5):754-760. PubMed ID: 29709912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoemulsion improves hypoglycemic efficacy of berberine by overcoming its gastrointestinal challenge.
    Xu HY; Liu CS; Huang CL; Chen L; Zheng YR; Huang SH; Long XY
    Colloids Surf B Biointerfaces; 2019 Sep; 181():927-934. PubMed ID: 31382342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose etoposide formulations do not saturate intestinal P-glycoprotein: Development, stability, and pharmacokinetics in Sprague-Dawley rats.
    Al-Ali AAA; Sandra L; Versweyveld D; Pijpers I; Dillen L; Vermeulen A; Snoeys J; Holm R; Nielsen CU
    Int J Pharm; 2020 Jun; 583():119399. PubMed ID: 32376439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced oral bioavailability of an etoposide multiple nanoemulsion incorporating a deoxycholic acid derivative-lipid complex.
    Jha SK; Han HS; Subedi L; Pangeni R; Chung JY; Kweon S; Choi JU; Byun Y; Kim YH; Park JW
    Drug Deliv; 2020 Dec; 27(1):1501-1513. PubMed ID: 33107339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of Paeonol Liposomes: Design, Optimization, in vitro and in vivo Evaluation.
    Huang S; Zhai B; Fan Y; Sun J; Cheng J; Zou J; Zhang X; Shi Y; Guo D
    Int J Nanomedicine; 2022; 17():5027-5046. PubMed ID: 36303804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel nanoemulsion based lipid nanosystems for favorable in vitro and in vivo characteristics of curcumin.
    Wan K; Sun L; Hu X; Yan Z; Zhang Y; Zhang X; Zhang J
    Int J Pharm; 2016 May; 504(1-2):80-8. PubMed ID: 27034002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of intestinal absorption of amtolmetin guacyl in rats: breast cancer resistant protein as a primary barrier of oral bioavailability.
    Rong Z; Xu Y; Zhang C; Xiang D; Li X; Liu D
    Life Sci; 2013 Feb; 92(3):245-51. PubMed ID: 23333829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.